Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2026)
Marimed (MRMD) posted quarterly Asset Writedowns and Impairment of $76000.0 for Q1 2026, down 94.52% year-over-year from $1.4 million in Q1 2025, and up 26.67% quarter-over-quarter from $60000.0 in Q4 2025.
Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Marimed (MRMD) has reported Asset Writedowns and Impairment for 7 consecutive years, with $76000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 94.52% year-over-year to $76000.0; the TTM figure through Mar 2026 stood at $270000.0 (down 74.33% YoY), while the FY2025 annual figure was $1.6 million, up 570.83% from the prior year.
- Asset Writedowns and Impairment advanced to $76000.0 in Q1 2026 per MRMD's latest filing, from $60000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q1 2025 and bottomed at -$205000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $174571.4 across 5 years, with a median of $39500.0 in 2022.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 6371.43% in 2023 and fell as far as 405.0% in 2023.
- Marimed's Asset Writedowns and Impairment stood at $40000.0 in 2022, then jumped by 512.5% to $245000.0 in 2023, then plunged by 183.67% to -$205000.0 in 2024, then soared by 129.27% to $60000.0 in 2025, then increased by 26.67% to $76000.0 in 2026.
- Business Quant data shows MRMD's Asset Writedowns and Impairment at $76000.0 in Q1 2026, $60000.0 in Q4 2025, and -$122000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 505,000.00 |
| Jun 30, 2026 | 505,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Sep 30, 2025 | -122,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 256,000.00 |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | -205,000.00 |
| Dec 31, 2024 | -205,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Sep 30, 2024 | -116,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Dec 31, 2023 | 245,000.00 |
| Dec 31, 2023 | 245,000.00 |